These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9858358)

  • 21. Detection of prolactin receptor mRNA in the corpus striatum and substantia nigra of the rat.
    Pi X; Voogt JL; Grattan DR
    J Neurosci Res; 2002 Feb; 67(4):551-8. PubMed ID: 11835322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical detection of L-DOPA-derived dopamine within serotonergic fibers in the striatum and the substantia nigra pars reticulata in Parkinsonian model rats.
    Yamada H; Aimi Y; Nagatsu I; Taki K; Kudo M; Arai R
    Neurosci Res; 2007 Sep; 59(1):1-7. PubMed ID: 17586078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Axonal transport of proteins and glycoproteins in the rat nigro-striatal pathway and the effects of 6-hydroxydopamine.
    Roger LJ; Breese GR; Morell P
    Brain Res; 1980 Sep; 197(1):95-112. PubMed ID: 6156743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tyrosine hydroxylase cells appearing in the mouse striatum after dopamine denervation are likely to be projection neurones regulated by L-DOPA.
    Darmopil S; Muñetón-Gómez VC; de Ceballos ML; Bernson M; Moratalla R
    Eur J Neurosci; 2008 Feb; 27(3):580-92. PubMed ID: 18279311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased expression of 5HT2 receptor mRNA in rat striatum following 6-OHDA lesions of the adult nigrostriatal pathway.
    Numan S; Lundgren KH; Wright DE; Herman JP; Seroogy KB
    Brain Res Mol Brain Res; 1995 Apr; 29(2):391-6. PubMed ID: 7609629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered melatonin MT
    Kang NH; Carriere CH; Bahna SG; Niles LP
    Brain Res; 2016 Dec; 1652():89-96. PubMed ID: 27693415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pirouetting pigs: A large non-primate animal model based on unilateral 6-hydroxydopamine lesioning of the nigrostriatal pathway.
    Christensen AB; Sørensen JCH; Ettrup KS; Orlowski D; Bjarkam CR
    Brain Res Bull; 2018 May; 139():167-173. PubMed ID: 29462643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclosporin A attenuates the decrease in tyrosine hydroxylase immunoreactivity in nigrostriatal dopaminergic neurons and in striatal dopamine content in rats with intrastriatal injection of 6-hydroxydopamine.
    Matsuura K; Makino H; Ogawa N
    Exp Neurol; 1997 Aug; 146(2):526-35. PubMed ID: 9270064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential expression of DCC mRNA in adult rat forebrain.
    Volenec A; Bhogal RK; Moorman JM; Leslie RA; Flanigan TP
    Neuroreport; 1997 Sep; 8(13):2913-7. PubMed ID: 9376530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glial bFGF and S100 immunoreactivities increase in ascending dopamine pathways following striatal 6-OHDA-induced partial lesion of the nigrostriatal system: a sterological analysis.
    Gomide V; Chadi G
    Int J Neurosci; 2005 Apr; 115(4):537-55. PubMed ID: 15809219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The distribution of 5-HT(6) receptors in rat brain: an autoradiographic binding study using the radiolabelled 5-HT(6) receptor antagonist [(125)I]SB-258585.
    Roberts JC; Reavill C; East SZ; Harrison PJ; Patel S; Routledge C; Leslie RA
    Brain Res; 2002 Apr; 934(1):49-57. PubMed ID: 11937069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced glutamatergic phenotype of mesencephalic dopamine neurons after neonatal 6-hydroxydopamine lesion.
    Dal Bo G; Bérubé-Carrière N; Mendez JA; Leo D; Riad M; Descarries L; Lévesque D; Trudeau LE
    Neuroscience; 2008 Sep; 156(1):59-70. PubMed ID: 18706980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 6-Hydroxydopamine lesions reduce BDNF mRNA levels in adult rat brain substantia nigra.
    Venero JL; Beck KD; Hefti F
    Neuroreport; 1994 Jan; 5(4):429-32. PubMed ID: 8003668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sequential changes of [H]forskolin, [H]cyclohexyladenosine and [H]PN200-110 binding sites in the brain of 6-hydroxydopamine-lesioned rats.
    Araki T; Tanji H; Kato H; Imai Y; Mizugaki M; Itoyama Y
    Acta Physiol Scand; 2000 May; 169(1):71-8. PubMed ID: 10759613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Susceptibility of ascending dopamine projections to 6-hydroxydopamine in rats: effect of hypothermia.
    Grant RJ; Clarke PB
    Neuroscience; 2002; 115(4):1281-94. PubMed ID: 12453497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morphological and biochemical adaptations to unilateral dopamine denervation of the neostriatum in newborn rats.
    Penit-Soria J; Durand C; Herve D; Besson MJ
    Neuroscience; 1997 Apr; 77(3):753-66. PubMed ID: 9070750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transient increase of brain derived neurotrophic factor mRNA expression in substantia nigra reticulata after partial lesion of the nigrostriatal dopaminergic pathway.
    Aliaga E; Cárcamo C; Abarca J; Tapia-Arancibia L; Bustos G
    Brain Res Mol Brain Res; 2000 Jun; 79(1-2):150-5. PubMed ID: 10925152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease.
    Oiwa Y; Yoshimura R; Nakai K; Itakura T
    Brain Res; 2002 Aug; 947(2):271-83. PubMed ID: 12176170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Upregulation of BDNF mRNA and trkB mRNA in the nigrostriatal system and in the lesion site following unilateral transection of the medial forebrain bundle.
    Venero JL; Vizuete ML; Revuelta M; Vargas C; Cano J; Machado A
    Exp Neurol; 2000 Jan; 161(1):38-48. PubMed ID: 10683272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response of the GABAergic and dopaminergic mesostriatal projections to the lesion of the contralateral dopaminergic mesostriatal pathway in the rat.
    González-Hernández T; Barroso-Chinea P; Rodríguez M
    Mov Disord; 2004 Sep; 19(9):1029-1042. PubMed ID: 15372592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.